Biopharma Business

Tag "Research and Development"

Innovation is key for pharmaceutical companies in a harsh market environment, says report

    Innovation is key for pharmaceutical companies in a harsh market environment, says report

Fewer than two in 10 medicines exceed the average pharmaceutical R&D cost required to bring a drug to market when the risks of failure to reach market approval are factored

Read Full Article

European Medicines Agency’s 2016 annual report published

    European Medicines Agency’s 2016 annual report published

The European Medicines Agency’s (EMA) 2016 annual report focuses on the Agency’s key achievements in the areas of medicine evaluation, support to research and development of new and innovative treatments and

Read Full Article

Report highlights economic benefits of UK life sciences

The report, commissioned by the Association of the British Pharmaceutical Industry (ABPI) and supported by the Association of the British Healthcare Industry (ABHI), the BioIndustry Association (BIA), and the British

Read Full Article

New biomarkers for bowel cancer treatment

One of Europe’s largest collaborative academic-industry research projects, designed to develop and assess novel approaches for identification of new markers for colon cancer, has been conducted by public-private consortium OncoTrack.

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements